WallStSmart

High Tide Inc (HITI)vsMerck & Company Inc (MRK)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Merck & Company Inc generates 9140% more annual revenue ($66.57B vs $720.47M). MRK leads profitability with a 4.8% profit margin vs -4.6%. HITI earns a higher WallStSmart Score of 43/100 (D).

HITI

Hold

43

out of 100

Grade: D

Growth: 9.3Profit: 4.0Value: 5.0Quality: 3.5
Piotroski: 2/9Altman Z: 0.68

MRK

Hold

36

out of 100

Grade: F

Growth: 4.0Profit: 4.5Value: 2.0Quality: 5.0
Piotroski: 3/9Altman Z: 2.27
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HITI.

MRKSignificantly Overvalued (-73.7%)

Margin of Safety

-73.7%

Fair Value

$83.64

Current Price

$146.35

$62.71 premium

UndervaluedFair: $83.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
32.8%10/10

Revenue surging 32.8% year-over-year

EPS GrowthGrowth
1532.0%10/10

Earnings expanding 1532.0% YoY

MRK2 strengths · Avg: 9.0/10
Market CapQuality
$360.08B10/10

Mega-cap, among the largest globally

Free Cash FlowQuality
$4.48B8/10

Generating 4.5B in free cash flow

Areas to Watch

HITI4 concerns · Avg: 2.8/10
Market CapQuality
$236.67M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.173/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-52.8%2/10

ROE of -52.8% — below average capital efficiency

MRK4 concerns · Avg: 3.3/10
Price/BookValuation
8.6x4/10

Trading at 8.6x book value

Return on EquityProfitability
7.6%3/10

ROE of 7.6% — below average capital efficiency

Profit MarginProfitability
4.8%3/10

4.8% margin — thin

Debt/EquityHealth
1.293/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth, EPS Growth. Revenue growth of 32.8% demonstrates continued momentum.

Bull Case : MRK

The strongest argument for MRK centers on Market Cap, Free Cash Flow.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Debt/Equity, Piotroski F-Score.

Bear Case : MRK

The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 115.8x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

HITI profiles as a hypergrowth stock while MRK is a value play — different risk/reward profiles.

HITI carries more volatility with a beta of 0.95 — expect wider price swings.

HITI is growing revenue faster at 32.8% — sustainability is the question.

MRK generates stronger free cash flow (4.5B), providing more financial flexibility.

Bottom Line

HITI scores higher overall (43/100 vs 36/100) and 32.8% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

Merck & Company Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.

Visit Website →

Want to dig deeper into these stocks?